Atezolizumab with cabozantinib for treating metastatic non-small-cell lung cancer after platinum-based chemotherapy and 1 PD-L1 checkpoint inhibitor TSID 11812

  • Topic prioritisation

Status:
Topic prioritisation
Technology type:
Medicine
Decision:
Prioritised
ID number:
11812

Project Team

Project lead
topic.selection@nice.org.uk

Email enquiries

If you have any queries please email topic.selection@nice.org.uk

For further information on how we select topics for development, please see our page about topic prioritisation